Advanced Search
Submit Manuscript Volume 28, No 5, May 2018
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 28 Issue 5, May 2018: 597-600
Xin Tian 1,2, Baofa Sun 3,4, Chuanyuan Chen 3,4, Chunchun Gao 3,4,Ji Zhang 1,2, Xingyu Lu 5,6, Linchen Wang 3,4, Xiangnan Li 7,Yurong Xing 7, Ruijuan Liu 1,2, Xiao Han 3,4, Zheng Qi 7,Xiaojian Zhang 1,2, Chuan He 8, Dali Han 3,4,Yun-Gui Yang 3,4 and Quancheng Kan 1,2
1 Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; 2 Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University,Zhengzhou, Henan 450052, China; 3 Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; 4 College of Future Technology, SinoDanish College, University of Chinese Academy of Sciences, Beijing 100049, China; 5 Shanghai Epican Genetech, Co. Ltd., Zhangjiang HiTech Park, Shanghai 201203, China; 6 Shanghai Epican Biotech, Co.Ltd., Qingpu, Shanghai 201799, China; 7 The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan, China and 8 Department of Chemistry, Department of Biochemistry and Molecular Biology, and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, The University of Chicago, Chicago, IL 60637, USA Correspondence: Dali Han (handl@big.ac.cn) or Yun-Gui Yang (ygyang@big.ac.cn) or Quancheng Kan (kanqc@zzu.edu.cn)